ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding ENvue Medical, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 9 | 0 | −9 |
| Shares | 363.3K | 0 | −363.3K (−100.0%) |
| Value | $215.3K | $0 | −$215.3K (−100.0%) |
New holders (0)
Institutions that held ENvue Medical, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (9)
Institutions that held ENvue Medical, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Armistice Capital, LLC | 189,300 | $111.7K |
| Citadel Advisors LLC | 43,621 | $25.9K |
| UBS Group AG | 41,235 | $24.3K |
| Vanguard Group Inc | 30,194 | $17.9K |
| Geode Capital Management, LLC | 22,519 | $13.4K |
| Virtu Financial LLC | 19,379 | $12.0K |
| Two Sigma Securities, LLC | 11,014 | $6.50K |
| Tower Research Capital LLC (TRC) | 6,049 | $3.57K |
| Bank of America Corp | 32 | $19 |